While more relevant to solid cancer treatment, much of this article provides a useful background to CLL treatment. Of particular interest is the natural origin of many cancer treatments covered in the section 'Where did we find the drugs?' The section 'Why the severe side effects?' is also of interest and explains why we are seeing second and third generation versions of proven drugs either in trial or recently approved for CLL.
Nial Wheate, BPharm Coordinator and Senior Lecturer, University of Sydney explains:
Be assured that CLL treatment trends are closely aligned to the more advanced methods mentioned in this article, in particular the use of immunotherapy (e.g. Mabthera/Rituximab, Gazyva/Obinutuzumab) and the increased development of personalised medicine.
Photo: Correa wildflower